Chronic pancreatitis nutrition market to grow from USD 214.6 Mn in 2026 to USD 434.1 Mn by 2036 at a 7.3% CAGR. Get segment, ...

With next-generation metabolic combinations continuing to set new standards in the clinic, type 2 diabetes and chronic weight ...

New research shows that diabetes elevates the histone mark H3K4me1 in pancreatic acinar cells, driving stress granule ...

Exactly what causes pancreatic cancer has long remained a mystery. But one scientist who has studied the disease for more ...

Two physicians reveal what really happens when you stop taking GLP-1 medications and the steps you should take before quitting.

The most common side effects are gastrointestinal—nausea, vomiting, diarrhea, and constipation. The drugs have also been ...

A regulator-mandated study using nationwide registry data from Denmark, Sweden and Norway found no increased risk of ...

MetaGO outlines its doctor-guided GLP-1 weight loss programme, combining medical assessments, personalised nutrition, ...

A lot of the discussion around GLP-1 medicines in recent years has highlighted the risks linked with rapid weight loss.

The symptoms aren't always easy to spot and are often dismissed as signs of ageing, so all the more reason to be vigilant ...

PRNewswire/ -- (NYSE: LLY), the maker of Zepbound (tirzepatide), today announced results from post-hoc analyses of ATTAIN-1 ...

Clinical obesity increased among U.S. adolescents over the past two decades, underscoring the urgent need for targeted ...